-
Study aim
-
comparing the levels of TSH, FT4, and FT3 in subclinical hypothyroid patients after treated with synbiotics versus placebo
-
Design
-
The present study is a randomized double-blind clinical trial study that will be conducted on 40 patients. Random allocation based on the table of random numbers, the synbiotic replacement blocks and its placebo will be divided into similar boxes.
-
Settings and conduct
-
In the present study, which will be conducted at Ali Bin Abi Taleb Hospital in Zahedan, 40 patients with subclinical hypothyroidism will be included in the study. treatment will generally be done within 8 weeks. The drug packages are completely similar in terms of shape and the patient and the plan administrator will not be aware of the contents of the packages. Fasting blood samples will be taken from these people before and after receiving the supplement or placebo to measure the level of thyroid hormones.
-
Participants/Inclusion and exclusion criteria
-
The inclusion criteria for this study are: age between 18 and 70 years
The Exclusion criteria are: lack of consent of the patients to enter the study, suffering from thyroid nodule, cancer, any type of infection or inflammatory disease, coronary artery disease, heart failure, gastrointestinal diseases, pregnancy, smoking addiction. and alcohol and antibiotic use in the last 3 monthes.
-
Intervention groups
-
After 8 weeks from the start of treatment (taking one synbiotic or placebo pill per day), TSH, FT4, anti tpo and FT3 tests are evaluated in both intervention and control groups.
-
Main outcome variables
-
TSH, FT4, FT3 and Anti Tpo; Time to evaluate thyroid tests in patients; Subclinical hypothyroid patients treated with probiotics and patients treated with placebo